Literature DB >> 17372702

Renal transport of adefovir, cidofovir, and tenofovir by SLC22A family members (hOAT1, hOAT3, and hOCT2).

Yuichi Uwai1, Hiroki Ida, Yoshie Tsuji, Toshiya Katsura, Ken-Ichi Inui.   

Abstract

PURPOSE: The nephrotoxicity of the nucleotide antivirals adefovir, cidofovir and tenofovir is considered to depend on the renal tubular transport of them. Although it is known that the antivirals are substrates of the human renal organic anion transporter hOAT1 (SLC22A6), there is no information available on other organic ion transporters. The aim of the present study was to investigate whether the other renal organic anion transporter hOAT3 (SLC22A8) and organic cation transporter hOCT2 (SLC22A2) transport the antivirals.
MATERIALS AND METHODS: Uptake experiments were performed using HEK293 cells transfected with cDNA of the organic ion transporters.
RESULTS: The uptake of adefovir, cidofovir and tenofovir in monolayers stably expressing hOAT3 increased time-dependently, compared with control. Probenecid, a typical inhibitor of organic anion transporters, completely inhibited their transport. The amounts of the antivirals taken up by hOAT3 were much lower than those by hOAT1. The transient expression of hOCT2 did not increase uptake of the antivirals.
CONCLUSION: These results indicate that adefovir, cidofovir and tenofovir are substrates of hOAT3 as well as hOAT1, but that quantitatively hOAT1 is the major renal transporter for these drugs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17372702     DOI: 10.1007/s11095-006-9196-x

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  18 in total

Review 1.  The multispecific organic anion transporter family: properties and pharmacological significance.

Authors:  Hiroki Miyazaki; Takashi Sekine; Hitoshi Endou
Journal:  Trends Pharmacol Sci       Date:  2004-12       Impact factor: 14.819

Review 2.  Organic anion transporter (Slc22a) family members as mediators of toxicity.

Authors:  Douglas H Sweet
Journal:  Toxicol Appl Pharmacol       Date:  2005-05-01       Impact factor: 4.219

3.  Gene expression levels and immunolocalization of organic ion transporters in the human kidney.

Authors:  Hideyuki Motohashi; Yuji Sakurai; Hideyuki Saito; Satohiro Masuda; Yumiko Urakami; Maki Goto; Atsushi Fukatsu; Osamu Ogawa; Ken-Ichi Inui
Journal:  J Am Soc Nephrol       Date:  2002-04       Impact factor: 10.121

4.  Association between tubular toxicity of cisplatin and expression of organic cation transporter rOCT2 (Slc22a2) in the rat.

Authors:  Atsushi Yonezawa; Satohiro Masuda; Kumiko Nishihara; Ikuko Yano; Toshiya Katsura; Ken-ichi Inui
Journal:  Biochem Pharmacol       Date:  2005-10-20       Impact factor: 5.858

Review 5.  Cellular and molecular aspects of drug transport in the kidney.

Authors:  K I Inui; S Masuda; H Saito
Journal:  Kidney Int       Date:  2000-09       Impact factor: 10.612

6.  Human renal organic anion transporter 1 (hOAT1) and its role in the nephrotoxicity of antiviral nucleotide analogs.

Authors:  T Cihlar; E S Ho; D C Lin; A S Mulato
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2001 Apr-Jul       Impact factor: 1.381

Review 7.  The SLC22 drug transporter family.

Authors:  Hermann Koepsell; Hitoshi Endou
Journal:  Pflugers Arch       Date:  2003-07-19       Impact factor: 3.657

8.  Multidrug resistance protein (MRP) 4- and MRP 5-mediated efflux of 9-(2-phosphonylmethoxyethyl)adenine by microglia.

Authors:  Shannon Dallas; Lyanne Schlichter; Reina Bendayan
Journal:  J Pharmacol Exp Ther       Date:  2004-02-04       Impact factor: 4.030

9.  cDNA cloning, functional characterization, and tissue distribution of an alternatively spliced variant of organic cation transporter hOCT2 predominantly expressed in the human kidney.

Authors:  Yumiko Urakami; Maiko Akazawa; Hideyuki Saito; Masahiro Okuda; Ken-Ichi Inui
Journal:  J Am Soc Nephrol       Date:  2002-07       Impact factor: 10.121

10.  Expression levels of renal organic anion transporters (OATs) and their correlation with anionic drug excretion in patients with renal diseases.

Authors:  Yuji Sakurai; Hideyuki Motohashi; Harumasa Ueo; Satohiro Masuda; Hideyuki Saito; Masahiro Okuda; Noriko Mori; Motokazu Matsuura; Toshio Doi; Atsushi Fukatsu; Osamu Ogawa; Ken-ichi Inui
Journal:  Pharm Res       Date:  2004-01       Impact factor: 4.200

View more
  53 in total

1.  Analysis of three-dimensional systems for developing and mature kidneys clarifies the role of OAT1 and OAT3 in antiviral handling.

Authors:  Megha A Nagle; David M Truong; Ankur V Dnyanmote; Sun-Young Ahn; Satish A Eraly; Wei Wu; Sanjay K Nigam
Journal:  J Biol Chem       Date:  2010-10-04       Impact factor: 5.157

2.  Pre-steady-state kinetic analysis of the incorporation of anti-HIV nucleotide analogs catalyzed by human X- and Y-family DNA polymerases.

Authors:  Jessica A Brown; Lindsey R Pack; Jason D Fowler; Zucai Suo
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

3.  A renal-like organic anion transport system in the ciliary epithelium of the bovine and human eye.

Authors:  Jonghwa Lee; Mohammad Shahidullah; Adam Hotchkiss; Miguel Coca-Prados; Nicholas A Delamere; Ryan M Pelis
Journal:  Mol Pharmacol       Date:  2015-02-06       Impact factor: 4.436

4.  Interactions between tenofovir and nevirapine in CD4+ T cells and monocyte-derived macrophages restrict their intracellular accumulation.

Authors:  N J Liptrott; P Curley; D Moss; D J Back; S H Khoo; A Owen
Journal:  J Antimicrob Chemother       Date:  2013-06-21       Impact factor: 5.790

Review 5.  Tenofovir-induced nephrotoxicity: incidence, mechanism, risk factors, prognosis and proposed agents for prevention.

Authors:  Atefeh Jafari; Hossein Khalili; Simin Dashti-Khavidaki
Journal:  Eur J Clin Pharmacol       Date:  2014-06-25       Impact factor: 2.953

6.  Renal handling of amphotericin B and amphotericin B-deoxycholate and potential renal drug-drug interactions with selected antivirals.

Authors:  František Trejtnar; Jana Mandíková; Jana Kočíncová; Marie Volková
Journal:  Antimicrob Agents Chemother       Date:  2014-06-23       Impact factor: 5.191

7.  Combination of tenofovir and emtricitabine plus efavirenz: in vitro modulation of ABC transporter and intracellular drug accumulation.

Authors:  Laurence Bousquet; Alain Pruvost; Anne-Cécile Guyot; Robert Farinotti; Aloïse Mabondzo
Journal:  Antimicrob Agents Chemother       Date:  2008-12-15       Impact factor: 5.191

8.  Molecular Mechanisms for Species Differences in Organic Anion Transporter 1, OAT1: Implications for Renal Drug Toxicity.

Authors:  Ling Zou; Adrian Stecula; Anshul Gupta; Bhagwat Prasad; Huan-Chieh Chien; Sook Wah Yee; Li Wang; Jashvant D Unadkat; Simone H Stahl; Katherine S Fenner; Kathleen M Giacomini
Journal:  Mol Pharmacol       Date:  2018-05-02       Impact factor: 4.436

9.  A pharmacogenetic candidate gene study of tenofovir-associated Fanconi syndrome.

Authors:  Amber Dahlin; Matthias Wittwer; Melanie de la Cruz; Jonathan M Woo; Rujuta Bam; Valeska Scharen-Guivel; John Flaherty; Adrian S Ray; Tomas Cihlar; Samir K Gupta; Kathleen M Giacomini
Journal:  Pharmacogenet Genomics       Date:  2015-02       Impact factor: 2.089

Review 10.  The nephrotoxic effects of HAART.

Authors:  Hassane Izzedine; Marianne Harris; Mark A Perazella
Journal:  Nat Rev Nephrol       Date:  2009-10       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.